Droxidopa Preparation via Enzymatic Resolution and Protecting Groups
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing Droxidopa face challenges in efficiently resolving the racemic (DL)-threo isomers to obtain the required (L)-threo isomer, particularly due to the use of expensive and potent chiral resolving agents, and the inefficiency of existing enzymatic processes like those using penicillin G acylase, which are not active on substrates without an aromatic ring.
Innovation Solution
An enzymatic process utilizing commercially available L-amino acylase from Aspergillus sp. in the presence of cobalt ions for the resolution of (DL)-threo-3-(3,4-methylenedioxyphenyl)serine, followed by dealkylation to produce Droxidopa, with the use of protecting groups like benzyloxycarbonyl or phthaloyl to enhance yields and purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If synthetic chiral amines (quinidine, quinine, ephedrine, (R)-aminodiphenyl propanol) are used as resolving agents, then the (L)-threo isomer can be obtained, but the process becomes expensive and complex due to the need for further crystallization and the expensive source materials
Solution Approach 1:
The patent introduces an enzyme (penicillin G acylase or amino acylase) as a biological intermediary to mediate the resolution of racemic (DL)-threo isomers. The enzyme selectively hydrolyzes the N-acyl group from one enantiomer, converting it to the free amine form, while leaving the other enantiomer unchanged. This biological mediator achieves chiral separation through enzymatic stereoselectivity, eliminating the need for complex chemical resolving agents and multiple crystallization steps.
Solution Approach 2:
The patent changes the chemical parameters of the substrate by introducing an N-acyl protecting group (N-acetyl or N-benzoyl) on the amino group of (DL)-threo-3-(3,4-methylenedioxyphenyl)serine. This parameter modification enables the substrate to become a suitable substrate for penicillin G acylase or amino acylase, which selectively hydrolyze the N-acyl group. The parameter change transforms an unresolved racemic mixture into a resolvable derivative that can be separated by enzymatic hydrolysis.
2Manufacturing precision
If penicillin G acylase is used for enzymatic resolution, then the process becomes more selective, but the enzyme is not active on substrates without an aromatic ring on the acyl group
Solution Approach 1:
The patent modifies the substrate parameters by introducing different N-acyl groups (acetyl, benzoyl) that match the specificity requirements of the enzymes. For penicillin G acylase, an aromatic ring on the acyl group is essential, so N-benzoyl protection is used. For amino acylase from Aspergillus sp., which lacks this aromatic ring requirement, N-acetyl protection suffices. This parameter matching enables enzymatic activity and selectivity.
Solution Approach 2:
The patent demonstrates that different enzymes (penicillin G acylase and amino acylase from Aspergillus sp.) can perform the same resolution function on differently protected substrates. Amino acylase from Aspergillus sp. shows broader versatility by acting on both N-acetyl and N-benzoyl derivatives, making the process more adaptable to different substrate designs while maintaining high stereoselectivity.
3Ease of manufacture
If dealkylation is performed without protecting groups, then the process is simpler, but the yield and purity of Droxidopa are reduced
Solution Approach 1:
The patent applies preliminary protection of the amino group with N-acyl groups (acetyl or benzoyl) before dealkylation. This preliminary action prevents side reactions during the dealkylation step and facilitates cleaner reaction conditions. The protecting group is removed after dealkylation is complete, ensuring high purity of the final Droxidopa product while maintaining relatively simple overall process steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process achieves selective and efficient resolution of the (L)-threo isomer with high chemical and chiral purity, overcoming the limitations of previous methods by using cobalt ions to activate the enzyme and protecting groups for improved dealkylation efficiency, resulting in high yields and pure Droxidopa production.
Implementation Method 1
resolution of racemic (DL)-threo mixture of (III) using L-amino acylase from Aspergillus sp. (EC 3.5.1.14.) to obtain (L)-threo-3-(3,4-methylenedioxyphenyl)serine (IV)
Implementation Method 2
enzymatic process utilizing commercially available L-amino acylase from Aspergillus sp. in the presence of cobalt ions for the resolution of (DL)-threo-3-(3,4-methylenedioxyphenyl)serine
Implementation Method 3
the role of cobalt ions in catalyzing the enzyme reaction. In the absence of cobalt ions, the yields are very low
Implementation Method 4
converting the (L)-threo isomer of formula (IV) to Droxidopa of formula (I)... Dealkylation of (IV) using aluminum chloride gives Droxidopa (I)
Implementation Method 5
use of protecting groups like benzyloxycarbonyl or phthaloyl to enhance yields and purity
Data Source
AI summary
A novel process for the preparation of L-threo-dihydroxyphenylserine (Droxidopa) is described. It comprises of enantioselective hydrolysis of racemic (DL)-threo-N-acetyl-3-(3,4-methylenedioxyphenyl)-serine using commercially available L-amino acylase from Aspergillus sp. (EC 3.5.1.14) in the presence of cobalt ions, to obtain (L)-threo-3-(3,4-methylenedioxyphenyl)-serine followed by dealkylation to obtain Droxidopa. Protecting the amino group of (L)-threo-3-(3,4-methylenedioxyphenyl)-serine using either benzyloxycarbonyl or phthaloyl group before dealkylation followed by deprotection of the amino group results in obtaining Droxidopa in high yields and purity.